| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
NuCana plc
13D/A
NCNA · 67022C205
|
5.1% |
2/14/2025
Event 2/14/2025
|
||||
| Sofinnova Capital VI FCPR | 5.1% | |||||
| Sofinnova Partners SAS | 5.1% | |||||
| Antoine Papiernik | 5.1% | |||||
| Henrijette Richter | 5.1% | |||||
| Maina Bhaman | 5.1% | |||||
| Graziano Seghezzi | 5.1% | |||||
| Anta Gkelou | 5.1% | |||||
| Karl Naegler | 5.1% | |||||
|
HOOKIPA Pharma Inc.
13D/A
HOOK · 43906K209
|
2.6% |
2/14/2025
Event 2/14/2025
|
||||
| Sofinnova Capital VI FCPR | 2.6% | |||||
| Sofinnova Partners SAS | 2.6% | |||||
| Antoine Papiernik | 2.6% | |||||
| Henrijette Richter | 2.6% | |||||
| Maina Bhaman | 2.6% | |||||
| Graziano Seghezzi | 2.6% | |||||
| Anta Gkelou | 2.6% | |||||
| Karl Naegler | 2.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.